353 followers
RT @HealthEconBot: #HealthEconJA Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disor…
RT @HealthEconBot: #HealthEconJA Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disor…
#HealthEconJA Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study) https://t.co/hIWtYFICBK